Location Charlottesville, Virginia, United States Regions East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Andy has more than 14 years of experience working in the life sciences industry and his career spans from research and development to sales and marketing. He was recently selected to be a member of the Mindshare Class of 2013 – an invite-only network of CEOs from the most promising technology and life sciences growth companies in the Greater
Washington Metropolitan region.
Prior to founding SphynKx, Andy was a management consultant in the Life Sciences Strategy & Operations Practice of Deloitte Consulting LLP. At Deloitte, Andy advised senior life science executives on a range of strategic issues including R&D strategy, global manufacturing, operational excellence, sales and marketing strategy, portfolio management, and post-merger integration.
Andy began his career as a cancer biologist with Millennium Pharmaceuticals, where he worked on the development of VELCADE, a blockbuster therapy for the treatment of multiple myeloma.
Andy has an MBA from the Darden School of Business at the University of Virginia, in addition to an M.S. in Pharmaceutical Sciences and a B.S. in Molecular Biology, both from the University of Connecticut.
